An observational study in Thyroid Disease, sponsored by University of Cagliari. Completed at 1 site in Italy. Per ClinicalTrials.gov, last updated 2020-11-19.
Sponsored by University of Cagliari · Observational
Italy has been on the frontline of the COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, the need to focus resources to deal with the pandemic led to a disruption of routine surgical care, as well as activity for oncologic and chronic disease. The aim of this study was to evaluate the impact of COVID-19 pandemic on surgical activity of the Italian Units of Endocrine Surgery belonging to the SIUEC (Italian Society of Endocrine Surgery), the most important national scientific society of endocrine surgery.The aim of this study was to evaluate the impact of COVID-19 pandemic on surgical activity of the Italian Units of Endocrine Surgery belonging to the SIUEC (Italian Society of Endocrine Surgery), the most important national scientific society of endocrine surgery.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 3,800 is above the median of 260 across 3,135 observational studies indexed under COVID-19.
Browse COVID-19 studies →University of Cagliari is the lead sponsor of 82 studies on the registry; 17 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients with thyroid disease
Exclusion Criteria:
Patients that underwent surgery during COVID-19 pandemic
Procedure: Thyroidectomy
Patients that underwent surgery during 2019
Procedure: Thyroidectomy
Thyroidectomy
Quantify the overall reduction of surgical activity for thyroid disease
Time frame: 1 year
Quantify if the number of thyroid cancers operated during COVID-19 pandemic was significant different from the number of patients operated during the same period of the previous year
Time frame: 1 year
Quantify the number of aggressive tumors operated during COVID-19 pandemic and the same period of the previous year
Comparison between the number of patients operated during COVID-19 pandemic with aggressive thyroid carcinoma (with lymph node metastasis, and/or extrathyroidal extension, and/or multifocality) with patients with aggressive thyroid carcinoma operated during the same period of the previous year
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Cagliari